In Brief: Grace reviewing NMC options
This article was originally published in The Gray Sheet
Executive Summary
Grace reviewing NMC options: W.R. Grace's newly elected president and CEO Albert Costello tells shareholders at Grace's May 10 annual meeting that the firm is weighing several alternatives for the divestiture of its National Medical Care dialysis unit. Last week, Grace received a $3.5 bil. acquisition offer for NMC from Constantine Hampers, a Grace executive VP and NMC's chairman and CEO ("The Gray Sheet" May 8, p. 14). "We are giving [Hampers'] proposal serious consideration and have retained the services of Merrill Lynch and First Boston to help us evaluate it," Costello told the stockholders in Boca Raton, Florida. Grace's board will "evaluate the Hampers proposal and other alternatives relating to NMC within approximately 30 to 60 days," the company said in a release...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.